These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 19253123

  • 1. Inhaled corticosteroid-related tooth problems in asthmatics.
    Han ER, Choi IS, Kim HK, Kang YW, Park JG, Lim JR, Seo JH, Choi JH.
    J Asthma; 2009 Mar; 46(2):160-4. PubMed ID: 19253123
    [Abstract] [Full Text] [Related]

  • 2. Effect of intermittent systemic corticosteroid on bone metabolism in bronchial asthma patients.
    Mori H, Tanaka H, Ohno Y, Ito F, Funaguchi N, Endo J, La BL, Minatoguchi S.
    J Asthma; 2009 Mar; 46(2):142-6. PubMed ID: 19253119
    [Abstract] [Full Text] [Related]

  • 3. Mineral status of COPD patients under long-term inhaled corticosteroid therapy.
    Buyukkaplan US, Akkaya A, Yildiz M, Bircan A, Aksoy Dogan A, Ozturk O.
    J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148
    [Abstract] [Full Text] [Related]

  • 4. Corticosteroid effects on proximal femur bone loss.
    Sambrook P, Birmingham J, Kempler S, Kelly P, Eberl S, Pocock N, Yeates M, Eisman J.
    J Bone Miner Res; 1990 Dec; 5(12):1211-6. PubMed ID: 2075834
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.
    Chen W, Johnson KM, FitzGerald JM, Sadatsafavi M, Leslie WD.
    Arch Osteoporos; 2018 Oct 29; 13(1):116. PubMed ID: 30374631
    [Abstract] [Full Text] [Related]

  • 6. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis.
    Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ.
    Ann Allergy Asthma Immunol; 2004 Feb 29; 92(2):201-7; quiz 207-8, 267. PubMed ID: 14989387
    [Abstract] [Full Text] [Related]

  • 7. Low bone mineral density in adult patients with moderate to severe atopic dermatitis.
    Haeck IM, Hamdy NA, Timmer-de Mik L, Lentjes EG, Verhaar HJ, Knol MJ, de Bruin-Weller MS, Bruijnzeel-Koomen CA.
    Br J Dermatol; 2009 Dec 29; 161(6):1248-54. PubMed ID: 19673879
    [Abstract] [Full Text] [Related]

  • 8. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids.
    Yeap SS, Fauzi AR, Kong NC, Halim AG, Soehardy Z, Rahimah S, Chow SK, Goh EM.
    Lupus; 2009 Feb 29; 18(2):178-81. PubMed ID: 19151123
    [Abstract] [Full Text] [Related]

  • 9. Oral health in patients on inhaled corticosteroid treatment.
    Komerik N, Akkaya A, Yildiz M, Buyukkaplan US, Kuru L.
    Oral Dis; 2005 Sep 29; 11(5):303-8. PubMed ID: 16120117
    [Abstract] [Full Text] [Related]

  • 10. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ, Damilakis J, Velegrakis GA, Skouteris CA, Fragouli I, Goumenou A, Matalliotakis J, Koumantakis EE.
    Maturitas; 2008 Mar 20; 59(3):226-33. PubMed ID: 18342460
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and etiology of low bone mineral density in juvenile systemic lupus erythematosus.
    Compeyrot-Lacassagne S, Tyrrell PN, Atenafu E, Doria AS, Stephens D, Gilday D, Silverman ED.
    Arthritis Rheum; 2007 Jun 20; 56(6):1966-73. PubMed ID: 17530722
    [Abstract] [Full Text] [Related]

  • 12. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.
    Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2004 Dec 20; 63(12):1576-80. PubMed ID: 15547081
    [Abstract] [Full Text] [Related]

  • 13. Use of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trøndelag Health Study (the HUNT Study).
    Langhammer A, Norjavaara E, de Verdier MG, Johnsen R, Bjermer L.
    Pharmacoepidemiol Drug Saf; 2004 Aug 20; 13(8):569-79. PubMed ID: 15317039
    [Abstract] [Full Text] [Related]

  • 14. Age-related bone mineral density, bone loss rate, prevalence of osteoporosis, and reference database of women at multiple centers in China.
    Cheng XG, Yang DZ, Zhou Q, Zhuo TJ, Zhang HC, Xiang J, Wang HF, Ou PZ, Liu JL, Xu L, Huang GY, Huang QR, Barden HS, Weynand LS, Faulkner KG, Meng XW.
    J Clin Densitom; 2007 Aug 20; 10(3):276-84. PubMed ID: 17604665
    [Abstract] [Full Text] [Related]

  • 15. Impact of treatment with inhaled corticosteroids on bone mineral density of patients with asthma: related with age.
    Monadi M, Javadian Y, Cheraghi M, Heidari B, Amiri M.
    Osteoporos Int; 2015 Jul 20; 26(7):2013-8. PubMed ID: 25860975
    [Abstract] [Full Text] [Related]

  • 16. Bone ultrasonometric features and growth hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy.
    Malerba M, Bossoni S, Radaeli A, Mori E, Romanelli G, Tantucci C, Giustina A, Grassi V.
    Bone; 2006 Jan 20; 38(1):119-24. PubMed ID: 16154397
    [Abstract] [Full Text] [Related]

  • 17. Effect of inhaled corticosteroids on forearm bone mineral density: the HUNT study, Norway.
    Langhammer A, Forsmo S, Lilleeng S, Johnsen R, Bjermer L.
    Respir Med; 2007 Aug 20; 101(8):1744-52. PubMed ID: 17433653
    [Abstract] [Full Text] [Related]

  • 18. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM, Elstein D, Hrebícek M, Zimran A.
    Clin Ther; 2007 Aug 20; 29(8):1645-54. PubMed ID: 17919546
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
    Marcén R, Caballero C, Uriol O, Fernández A, Villafruela JJ, Pascual J, Martins J, Rodriguez N, Burgos FJ, Ortuño J.
    Transplant Proc; 2007 Sep 20; 39(7):2256-8. PubMed ID: 17889156
    [Abstract] [Full Text] [Related]

  • 20. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep 20; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.